RNA Formulation Resources
-
Transforming Nanoparticle Processing Through Innovation
6/27/2025
Learn about an innovative closed, single-use system and proprietary mixing technology aimed at improving reproducibility and reducing contamination risks in biopharma manufacturing.
-
Developing Non-PEG Stabilizer Lipids For Nucleic Acid Lipid Nanoparticles
7/1/2026
Non-PEG stabilizer lipids may offer a new path for LNP design. Combining strong colloidal performance with greater chemical flexibility helps address growing concerns around PEG-related immunogenicity.
-
Purification And QC Of An RNA 21‑Mer Oligonucleotide Via LC‑MS
1/27/2026
Learn how buffer choice, gradient strategy, and pretreatment steps influence recovery, purity, and resolution when purifying a native RNA oligo, with analytical confirmation and practical guidance.
-
Development And Optimization Of LNP Formulations
12/6/2024
The production of lipid nanoparticles (LNPs) is a process that demands robustness, scalability, and reproducibility. Examine the impact of key operational parameters on the efficacy of LNPs.
-
How Lipid Nanoparticles Enable Next-Gen Delivery
10/20/2025
Cell therapy’s future depends on smarter gene delivery. Learn how lipid nanoparticles offer a scalable, cell-friendly alternative to electroporation and viral vectors for manufacturing efficiency.
-
How To Make The Best LNPs
1/22/2024
There are various factors that require careful consideration throughout the process of formulating LNPs and utilizing them for successful mRNA delivery and translation.
-
Lipid Nanoparticles Boost CRISPR HDR Gene Insertion in Human T Cells
12/12/2025
Lipid nanoparticles enable precise, non-viral gene editing in T cells to achieve high HDR efficiency and viability in scalable workflows. Explore how this approach overcomes viral vector limitations.
-
Versatile Lipid Nanoparticle Platform For Efficient Gene Editing
6/3/2025
Lipid nanoparticles enable efficient gene editing in hard-to-transfect cells like T-cells and blood stem cells, which offers scalable, clinically relevant methods for developing advanced therapies for cancer and rare diseases.
-
The Critical Bottleneck In Personalized Cancer Vaccines
6/19/2026
Personalized cancer vaccines face a DNA production bottleneck. Synthetic approaches speed timelines, boost consistency, and simplify workflows to deliver individualized therapies faster.
-
From Proof To Promise: The Future Of Genome Editing Therapeutics
9/25/2026
CRISPR's potential depends on more than biology. Learn how advances in delivery, safety, manufacturing, and regulation are enabling clinical translation at scale.